RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @NatRevClinOncol: In a comprehensive genomic & transcriptomic analysis to guide treatment decisions in 1,138 pts with rare cancers, 31.8…
RT @NatRevClinOncol: In a comprehensive genomic & transcriptomic analysis to guide treatment decisions in 1,138 pts with rare cancers, 31.8…
RT @NatRevClinOncol: In a comprehensive genomic & transcriptomic analysis to guide treatment decisions in 1,138 pts with rare cancers, 31.8…
RT @NatRevClinOncol: In a comprehensive genomic & transcriptomic analysis to guide treatment decisions in 1,138 pts with rare cancers, 31.8…
In a comprehensive genomic & transcriptomic analysis to guide treatment decisions in 1,138 pts with rare cancers, 31.8% received recommended therapies, which resulted in a significantly improved ORR & DCR (23.9% and 55.3%) compared to previous ther
RT @ElizSMcKenna: Online now in @CD_AACR: Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients w…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: We are excited to see this work published and hope it will help improve our understanding and clinical management of #R…
RT @StefanFrohling: We are excited to see this work published and hope it will help improve our understanding and clinical management of #R…
RT @StefanFrohling: We are excited to see this work published and hope it will help improve our understanding and clinical management of #R…
RT @StefanFrohling: We are excited to see this work published and hope it will help improve our understanding and clinical management of #R…
RT @StefanFrohling: We are excited to see this work published and hope it will help improve our understanding and clinical management of #R…
RT @StefanFrohling: We are excited to see this work published and hope it will help improve our understanding and clinical management of #R…
RT @ElizSMcKenna: Online now in @CD_AACR: Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients w…
RT @StefanFrohling: We are excited to see this work published and hope it will help improve our understanding and clinical management of #R…
'These data demonstrate the benefit of molecular stratification in rare cancers and represent a resource that may promote clinical trial access and drug approvals in this underserved patient population.' https://t.co/aLn5btwzHX
RT @StefanFrohling: We are excited to see this work published and hope it will help improve our understanding and clinical management of #R…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @ElizSMcKenna: Online now in @CD_AACR: Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients w…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: We are excited to see this work published and hope it will help improve our understanding and clinical management of #R…
RT @StefanFrohling: We are excited to see this work published and hope it will help improve our understanding and clinical management of #R…
RT @StefanFrohling: We are excited to see this work published and hope it will help improve our understanding and clinical management of #R…
RT @StefanFrohling: We are excited to see this work published and hope it will help improve our understanding and clinical management of #R…
RT @StefanFrohling: We are excited to see this work published and hope it will help improve our understanding and clinical management of #R…
Remarkable results in a difficult clinical scenario… IMPACT-SG has made some difference for us, but the added value of transcription is undeniable.
RT @StefanFrohling: We are excited to see this work published and hope it will help improve our understanding and clinical management of #R…
RT @StefanFrohling: We are excited to see this work published and hope it will help improve our understanding and clinical management of #R…
RT @StefanFrohling: We are excited to see this work published and hope it will help improve our understanding and clinical management of #R…
RT @StefanFrohling: We are excited to see this work published and hope it will help improve our understanding and clinical management of #R…
We are excited to see this work published and hope it will help improve our understanding and clinical management of #RareCancers such as bone and soft-tissue #Sarcoma. Please get in touch if you are interested in collaborating with us!
RT @fedenichetti: A must read from @NCT_HD and @DKFZ !!
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers https://t.co/6zp8l6PS8S
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers https://t.co/FGPmiVfPBA https://t.co/XRHPcTOfTM
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers https://t.co/27EGgZl05q https://t.co/e9TgBuTiDa
RT @aftimosp: Huge effort in the field of #PrecisionMedicine : 🔹Molecular profiling 🧬of rare cancers 🔹Cross-institutional molecular tumor…
Huge effort in the field of #PrecisionMedicine : 🔹Molecular profiling 🧬of rare cancers 🔹Cross-institutional molecular tumor board👩💻👨💻(management recommendations, diagnostic reevaluation, genetic counseling, & experimental treatment) 🔹Treatment acces
Just published #OnlineFirst: Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers. https://t.co/BOdaPP2cSo https://t.co/5QXmWWZyb8
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @ElizSMcKenna: Online now in @CD_AACR: Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients w…
#PrecisionMedicine for patients with rare cancers by comprehensive molecular analysis
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
Very interesting work from @StefanFrohling and colleagues from Heidelberg on #rarecancers published in Cancer Discovery. The thread under his tweet reflects #teamwork and a lot of ambition to crack the problem of these often difficult to treat cancers.
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @ElizSMcKenna: Online now in @CD_AACR: Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients w…
Important and impressive study by @StefanFrohling and colleagues!
Impressive, personalized medicine for patients with rare cancers, shows the true value of whole genome/exome, RNA sequencing, and tumor board. Tour de force for tailored treatment. The future is here. Congratulations to @StefanFrohling and the entire team.
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @ElizSMcKenna: Online now in @CD_AACR: Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients w…
RT @ElizSMcKenna: Online now in @CD_AACR: Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients w…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @ElizSMcKenna: Online now in @CD_AACR: Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients w…
RT @ElizSMcKenna: Online now in @CD_AACR: Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients w…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @ElizSMcKenna: Online now in @CD_AACR: Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients w…
Online now in @CD_AACR: Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with #RareCancers (from the @DKTK_ MASTER Program) @StefanFrohling @DKFZ @NCT_HD @TMO_Heidelberg @uniklinik_hd @NCT_UCC_DD https://t.co/
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
#Genomics for clinical & therapeutic decision making 👇
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
For those who say that NGS is still not very useful in the clinic or that there is no knowledge to drive therapeutic value when sequence a patient's tumour, this paper is an example that says: is does have value but you must join forces! 👇👇👇 Congratulatio
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
Congrats Peter Horak, @StefanFrohling @DKFZ @GFolprecht for this multi- disciplinary team effort of German University Hospitals i.e. @Medizin_TUD @UniklinikEssen @uniklinik_hd and the NCT/UCC sites
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…
RT @StefanFrohling: Please read our new paper on the use of whole-genome/exome and RNA sequencing for therapeutic decision-making in patien…